(MENAFN- Trend News Agency)
Pfizer Inc and partner BioNTech SE said on Wednesday they signed
a $3.2 billion deal with the U.S. government for 105 million doses
of their COVID-19 vaccine, which could be delivered as soon as
later this summer, Trend reports citing Reuters .
The deal includes supplies of a retooled Omicron-adapted
vaccine, pending regulatory clearance, according to Pfizer.
Drugmakers have been developing vaccines to target the Omicron
variant that became dominant last winter.
The average price per dose in the new deal is over $30, a more
than 50% increase from the $19.50 per dose the U.S. government paid
in its initial contract with Pfizer.
Some of the vaccine earmarked for adults included in the
contract will be in single-dose vials, which are more expensive to
manufacture but reduce waste of unused shots from open vials.
'We look forward to taking delivery of these new
variant-specific vaccines and working with state and local health
departments, pharmacies, healthcare providers, federally qualified
health centers, and other partners to make them available in
communities around the country this fall,' U.S. Health and Human
Services (HHS) official Dawn O'Connell said in a statement.
Advisers to the U.S. Food and Drug Administration on Tuesday
recommended a change in the design of COVID-19 booster shots for
this fall in order to combat more recently circulating variants of
The U.S. government also has the option to purchase up to 195
million additional doses, bringing the total number of potential
doses to 300 million, the companies said.
The new contract should boost 2022 vaccine sales for Pfizer and
BioNTech, which share profits from the shots. Pfizer has forecast
COVID-19 vaccine sales of $32 billion this year. Analysts, on
average, have forecast 2022 sales of around $33.6 billion for the
The U.S. government has distributed close to 450 million doses
of the Pfizer/BioNTech vaccine in the United States since it was
first authorized in December 2020, according to data from the U.S.
Centers for Disease Control and Prevention. Over 350 million of
those doses have been administered.
Because the Biden administration was unable to line up more
COVID-19 funding from Congress earlier this month, it was forced to
reallocate $10 billion of existing funding to pay for additional
vaccines and treatments.
According to HHS, the money to pay for doses in this new
contract comes from that funding.
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.